2025
info:eu-repo/semantics/openAccess
adelage, « Catapult's Network established to identify opportunities for regulation to support innovation within advanced therapies », ELSIBI, ID : 10.58079/13yf5
London, United Kingdom, [Monday 10th February 2025]: A new network will foster collaboration among regulators, industry, and researchers to ensure there is a world-leading regulatory environment in the UK for advanced therapies that supports companies in the development, trial, and launch of these innovative treatments. Cell and Gene Therapy Catapult (CGT Catapult), an independent innovation and technology organisation specialising in the advancement of the cell and gene therapy industry, and the...